Astera Labs Valuation
Is ALAB * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ALAB * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ALAB * (MX$785.19) is trading above our estimate of fair value (MX$767.36)
Significantly Below Fair Value: ALAB * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ALAB *?
Other financial metrics that can be useful for relative valuation.
What is ALAB *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$8.21b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 32.1x |
Enterprise Value/EBITDA | -75.3x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ALAB *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 5x | ||
600584 JCET Group | 1.9x | 10.3% | CN¥63.2b |
MTSI MACOM Technology Solutions Holdings | 11.8x | 14.6% | US$8.1b |
2379 Realtek Semiconductor | 2.3x | 12.3% | NT$241.6b |
600703 Sanan OptoelectronicsLtd | 3.9x | 18.5% | CN¥60.1b |
ALAB * Astera Labs | 35.8x | 30.8% | Mex$8.2b |
Price-To-Sales vs Peers: ALAB * is expensive based on its Price-To-Sales Ratio (35.8x) compared to the peer average (5x).
Price to Earnings Ratio vs Industry
How does ALAB *'s PE Ratio compare vs other companies in the Global Semiconductor Industry?
Price-To-Sales vs Industry: ALAB * is expensive based on its Price-To-Sales Ratio (35.8x) compared to the Global Semiconductor industry average (3.2x).
Price to Sales Ratio vs Fair Ratio
What is ALAB *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 35.8x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate ALAB *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.